Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype
- PMID: 21330329
- PMCID: PMC3069244
- DOI: 10.3324/haematol.2010.037838
Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype
Figures
Comment in
-
Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrum.Haematologica. 2011 Apr;96(4):491-3. doi: 10.3324/haematol.2011.043208. Haematologica. 2011. PMID: 21454879 Free PMC article. No abstract available.
References
-
- Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) Blood. 2002;100(13):4325–36. - PubMed
-
- Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998;92(7):2322–33. - PubMed
-
- Mrozek K, Bloomfield CD. Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia. Hematology Am Soc Hematol Educ Program. 2006:169–77. - PubMed
-
- Mrozek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood Rev. 2004;18(2):115–36. - PubMed
-
- Breems DA, Van Putten WL, De Greef GE, Van Zelderen-Bhola SL, Gerssen-Schoorl KB, Mellink CH, et al. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol. 2008;26(29):4791–7. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
